The Global Virus Network Bolsters Multinational Mpox Response Through Critical Meeting of Key Global Partners
TAMPA, Fla., Aug. 29, 2024 (GLOBE NEWSWIRE) -- To mitigate the mpox outbreak, the Global Virus Network (GVN) is leading a panel of experts to develop guidelines and streamline testing standards, including strengthening infrastructure to sequencing and early detection. On August 22, 2024, the GVN, headquartered at the University of South Florida, USA, convened a critical mpox discussion online with leaders from the World Health Organization (WHO), Africa Centers for Disease Control and Prevention (Africa CDC), the Foundation for Innovative New Diagnostics (FIND), the Coalition for Epidemic Preparedness Innovations (CEPI), major industry partners, renowned virologists, and public health experts at the forefront of the mpox outbreak response.
- Lorenzo Subissi, PhD, WHO’s Mpox Task Force lead, advised the group that the current mpox epidemic was escalated to a grade 3 emergency, requiring a major to maximal WHO response.
- He reported that 38% of children infected are under age 10 and noted sustained human-to-human transmission of clade 1b in Africa.
- Mpox is a viral infection that spreads through close contact, including sexual relations, and causes flu-like symptoms, including fever, chills, muscle aches, and pus-filled lesions.
- To effectively combat this virus, we must strengthen our surveillance, diagnostic, and response capabilities across Africa.